Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): Price and Financial Metrics
GET POWR RATINGS... FREE!
AVDL Stock Price Chart Interactive Chart >
AVDL Price/Volume Stats
Current price | $8.40 | 52-week high | $10.20 |
Prev. close | $8.89 | 52-week low | $1.05 |
Day low | $8.00 | Volume | 3,928,116 |
Day high | $8.44 | Avg. volume | 492,811 |
50-day MA | $8.47 | Dividend yield | N/A |
200-day MA | $6.61 | Market Cap | 518.94M |
Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) Company Bio
Avadel Pharmaceuticals plc develops and commercializes pharmaceutical products based on its proprietary drug delivery technology for primary care and sterile injectable markets in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. The company was founded in 1990 and is based in Dublin, Ireland.
Latest AVDL News From Around the Web
Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.
Avadel Pharma enters into royalty agreement with RTW investments for up to $75M
|
Avadel Pharmaceuticals Announces Proposed Underwritten Public Offering of ADSs and Series B Preferred SharesDUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (“Avadel”) (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is commencing an underwritten public offering of its ordinary shares, nominal value $0.01 per share (“Ordinary Shares”) in the form of American Depositary Shares (“ADSs”). Each ADS represents the right to receive one Ordinary Share. Avadel may, in lieu of ADSs, offer and sell to certain |
Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million– In parallel, extended maturity on $96.2 million of convertible notes to April 1, 2027 – Strategic financings strengthen the company’s balance sheet in advance of potential commercialization of LUMRYZ DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced its entry into a royalty agreement with RTW Investments, LP and certain of its affiliates (“RTW”) for up |
Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ™ Ahead of Anticipated Final Approval DecisionImportation of LUMRYZ to the U.S. shortens the time to product availability following a final approval decisionDUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its Pre-Launch Activities Importation Requests (PLAIR) for LUMRYZ. Through its PLAIR, Avadel is authorized to import unapproved drug |
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DUBLIN, Ireland, March 21, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to one (1) new employee to purchase 15,000 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance wit |
AVDL Price Returns
1-mo | -15.58% |
3-mo | 17.32% |
6-mo | 67.66% |
1-year | 19.66% |
3-year | -3.67% |
5-year | 15.23% |
YTD | 17.32% |
2022 | -11.39% |
2021 | 20.96% |
2020 | -11.52% |
2019 | 192.64% |
2018 | -68.54% |
Continue Researching AVDL
Want to see what other sources are saying about Avadel Pharmaceuticals Plc's financials and stock price? Try the links below:Avadel Pharmaceuticals Plc (AVDL) Stock Price | Nasdaq
Avadel Pharmaceuticals Plc (AVDL) Stock Quote, History and News - Yahoo Finance
Avadel Pharmaceuticals Plc (AVDL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...